A randomized clinical trial of dose-dense chemotherapy in early-stage breast cancer found the regimen to be safe, with a 13% reduced risk of death. However, the dose-dense treatment increased acute toxic effects such as anemia and bone pain, but these were mild and easy to manage.
Estradiol induces apoptosis by activating the intrinsic apoptotic pathway, which controls protein expression and mitochondrial function. The study found complete tumor regression in mice with estradiol-treated breast cancer cells, suggesting a potential strategy for aromatase inhibitor resistance.
A new study found that increased physical activity is associated with a decreased risk of breast cancer in both black women and white women, regardless of disease stage or family history. Additionally, research on plant compound deguelin suggests it may interfere with tobacco-induced lung cancer development, while high plasma levels of...
A follow-up study to the NSABP Breast Cancer Prevention Trial confirms tamoxifen's effectiveness in reducing invasive and noninvasive breast cancer risk. The study found a 43% reduction in invasive breast cancer risk and a 37% reduction in noninvasive breast cancer risk.
A new variant of retinoic acid receptor beta has been discovered, which may play a role in vitamin A resistance in lung cancer. The variant, RAR-beta-1', was found to be expressed in normal lung cells and sensitive to retinoic acid, but not in resistant or lung cancer cells.
Alcohol consumption is linked to increased ER-positive breast cancer risk in postmenopausal women. Tamoxifen treatment for 5 years reduces death from coronary heart disease compared to 2-year treatment, according to a new study. The gamma-linolenic acid found in herbal medicine has been shown to affect the expression of the Her-2/neu o...
Researchers followed nearly 1.7 million offspring and siblings of almost 850,000 people with cancer diagnoses to investigate familial cancer risks. The study found that daughters of breast cancer patients were more likely to be diagnosed with in situ breast cancer within a year of their mother's diagnosis.
A recent study found that post-treatment conception was successful in 71% of testicular cancer survivors within 15 years and 76% within 20 years. The success rate varied by type of treatment, with men treated with higher doses of chemotherapy having lower fertility rates.
Researchers found that individuals carrying CDKN2A mutations have a significantly higher risk of developing melanoma by age 50 (14%), 70 (24%), and 80 (28%). Genetic testing is unlikely to identify many mutation carriers due to the modest impact of these mutations on population incidence.
Researchers have found that combining the monoclonal antibody C225 with photodynamic therapy in a mouse model of ovarian cancer resulted in substantial tumor reduction and improved survival rates compared to single-agent treatments. This innovative approach may provide new hope for women diagnosed with this aggressive form of cancer.
A recent study examined mortality and complications within 30 days following radical prostatectomy in 11,010 men who underwent the surgery between 1990 and 1999. The study found that age was associated with an increased risk of 30-day mortality, but the absolute risk of death was low even among men ages 70 to 79.
Despite declining overall mortality, US cancer incidence rose slightly among women in 2002 compared to the previous decade. The study also found that some cancers, like leukemia and non-Hodgkin lymphoma, experienced increased incidence.
Researchers found no link between breast-feeding and adult cancer risk, but high red meat consumption is associated with increased pancreatic cancer risk. A new vaccine approach may enhance tumor-specific immune response when combined with chemotherapy.
A model predicts that young women treated for Hodgkin lymphoma are at increased risk of developing breast cancer, with risks rising with age and radiation exposure. Current treatment guidelines may be reconsidered to minimize these risks.
Men who survive testicular cancer are at higher risk of developing a second cancer for at least 35 years after diagnosis, mostly due to late side effects of treatment. Cancers such as bladder, colon, and stomach cancers account for most excess risks, with young patients facing even greater dangers.
A study of nearly 60,000 French women found that beta-carotene intake was inversely associated with tobacco-related cancer risk in never-smokers, but increased the risk in former and current smokers. The researchers also calculated that the absolute rates of tobacco-related cancers over 10 years varied significantly between nonsmoking ...
A recent study found that 50-94% of colorectal tumors have DNA gene changes, which could indicate a molecular defect. The study also found normal colon mucosa up to 10cm away from the tumor had similar gene changes.
Researchers found that women taking letrozole experienced a significantly better overall disease-free survival rate and distant disease-free survival rate compared to those on placebo. This study confirms the protective effect of extended adjuvant letrozole therapy for postmenopausal breast cancer patients.
A study found that nearly 60% of prostate cancer specimens received higher Gleason scores than original assignments, suggesting that pathologists are more likely to assign high scores to contemporary tumor samples. This 'Will Rogers phenomenon' may lead to a false sense of therapeutic accomplishment and skew mortality rates.
Researchers found ER-positive/PR-negative tumors may be more aggressive and respond poorly to tamoxifen, while EDNRB mutations are linked to melanoma risk. Farnesyltransferase inhibitors show promise against aerodigestive tract cancer cells.
Researchers found that screen-detected breast cancers tend to have better prognoses than clinically detected ones, but may not lead to lower mortality. Meanwhile, patients on cetuximab therapy are at risk of hypomagnesemia and require magnesium supplementation. Additionally, men with Klinefelter syndrome may be more likely to develop c...
Researchers found that gefitinib was more effective at inhibiting cell growth and increasing apoptosis in NSCLC cells with mutant EGFR. In contrast, cetuximab showed no significant response in patients with EGFR mutations.
Research has found a positive association between body mass index, fat-free mass, and waist circumference with an increased risk of myeloid leukemia. Additionally, modifications of the vimentin gene can be detected in fecal DNA of people with colon cancer, potentially serving as a biomarker for the disease.
A study evaluated the Quebec Neuroblastoma Screening Project and found that not implementing screening programs saved $574.1 million in unnecessary health costs. The study also found that widespread use of neuroblastoma screening across North America would have caused adverse health effects.
Lowering PSA cutoff from 4.0 ng/mL to 2.5 ng/mL would call for more biopsies, with 10.7% of US men aged 50-59 and 17% of those aged 60-69 affected.
A study of 1,351 deceased women and 2,501 cancer-free women found similar screening rates among both groups. Women with increased risk showed a 26% reduction in mortality, but this was not statistically significant.
A study analyzed data from 18 published studies on TP53 protein and mortality rates, finding selective reporting biases that may have fabricated strong associations. The authors caution that the findings highlight limitations of current research methods and call for more transparent reporting and better study design.
Researchers identify HPV types 16 and 18 as key factors in cervical precancer development, supporting targeted management for high-risk women. Night-shift work linked to increased breast cancer risk, while melatonin levels found to lower risk.
A study analyzing over 180,000 breast cancer cases found that inflammatory breast carcinoma (IBC) accounts for about 2% of all breast cancers. Women diagnosed with IBC tend to be younger and have poorer survival rates compared to other types of breast cancer.
Men with prostate cancer are 10% less likely to be working six months after diagnosis compared to those without the disease. However, approximately two-thirds of patients continue to work due to fear of losing health insurance coverage, often at reduced hours and with decreased productivity.
A new study found long-duration regular use of aspirin or NSAIDs may lower prostate cancer risk by 18%. Gene variants associated with melanoma risk were also identified in a Mediterranean population study, while another study found no link between gene mutations and response to bevacizumab
A phase I study found that glioma patients who responded to erlotinib treatment had higher levels of EGFR expression and amplification. The level of phosphorylated PKB/Akt was also associated with response to erlotinib, as well as time to progression.
A study examines the cost-effectiveness of HPV testing in France, Italy, the Netherlands, and the UK, finding both triage and combination strategies to be more effective than current cytology-based screening programs. The cost-effectiveness ratios range from $9,800 to $75,900 per year of life saved, depending on the screening interval.
A new study found that anal cancer precursors are common among HIV-negative, sexually active men who have sex with men, regardless of age. The study also identified risk factors for these precancerous lesions, including HPV infection and having multiple male sex partners.
A randomized trial of 900 patients with breast or prostate cancer found that a shorter course of radiation therapy was as effective as the standard treatment in providing pain relief. The study also showed less acute toxicity and re-treatment rates in patients who received a single dose of 8 Gy radiation.
A study by Beth E. Meyerowitz and colleagues found that cancer survivors are twice as likely to experience cognitive deficits, including dementia, compared to their cancer-free twins. The authors suggest that cancer treatments may lower survivors' cognitive reserve, leading to increased risk of long-term cognitive dysfunction.
Research on the ATM gene suggests that women carrying one mutated copy are twice as likely to develop breast cancer, with a lifetime risk of one in six compared to one in 11 in the general population. Meanwhile, a new study on ursodeoxycholic acid treatment found a 39% reduction in colorectal adenoma recurrence among patients who recei...
A new study found that long-term daily use of aspirin was associated with an increased risk of ER/PR-negative breast cancer, while long-term daily use of ibuprofen was linked to a higher risk of nonlocalized breast cancer. Regular NSAID use was not associated with breast cancer risk.
A case-control study found a strong dose-response relationship between radiation dose and thyroid cancer risk, with iodine-deficient areas showing three times the risk. Stable iodine supplementation was associated with one-third the risk of radiation-related thyroid cancer compared to no supplementation.
A new study found that increasing breast cancer screening recall rates can detect more breast cancers earlier, but the benefit levels off. Premenopausal women with elevated hormone levels have an increased risk of breast cancer.
A new protein targets tumor vasculature by inducing coagulation when administered systemically, delaying tumor growth and producing some tumor regressions. The treatment shows promise for cancer therapy, adding a powerful punch to the fight against cancer.
Researchers found that advanced NSCLC patients with high EGFR gene copy number, protein expression, or mutations respond better to gefitinib. High EGFR gene copy number is associated with prolonged survival and disease control.
A new study found that increasing Pap screening adherence and improving its accuracy could reduce the incidence of invasive cervical cancer among women with access to screening. The study also identified factors associated with screening failure, including lack of Pap testing and unrelated outpatient visits.
A telephone survey found that celebrity endorsements increased awareness and likelihood of certain cancer screenings, including mammography, PSA testing, and sigmoidoscopy. The study highlights the complex decision-making process around cancer screening, suggesting a need for celebrities to inform rather than persuade the public.
A clinical trial found that systematic aortic and pelvic lymphadenectomy improved progression-free survival, but not overall survival, in patients with advanced ovarian cancer. The procedure did not significantly increase median overall survival duration.
Research investigates associations between male breast cancer, human papillomavirus (HPV) infections, and genetic variants in DNA repair genes. Ionizing radiation exposure is linked to higher male breast cancer incidence among atomic bomb survivors, while HPV detection is strongly associated with HIV status. Genetic polymorphisms in DN...
A meta-analysis of 27 clinical trials found that erythropoietin treatment lowers the likelihood of needing a blood transfusion and improves hematologic response in cancer patients. However, results on overall survival are inconclusive, suggesting erythropoietin should not be used to increase survival outside clinical trials.
A new study found that altering food schedules and light/dark exposure in mice modified the expression of circadian clock genes and genes involved in carcinogenesis and tumor progression. The authors conclude that the altered light/dark or feeding schedules may slow tumor growth in chronic jet-lagged mice.
Two trials found that menopausal hormone therapy may increase breast cancer recurrence risk, but a new trial suggests no association. Researchers call for further study on safe treatment regimens.
A multicenter trial found that alpha-tocopherol supplementation increased the rate of developing a second primary cancer during treatment but reduced the risk after treatment ended. After 8 years, the proportion of participants free of a second primary cancer was similar in both groups.